Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide
Authors:
- Frederick C. MorinFMFrederick C. Morin
- 1 May 1993
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 122 (5) , 743-750
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inhaled nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992
- Pulmonary hemodynamics in fetal lambs during development at normal and increased oxygen tensionJournal of Applied Physiology, 1992
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionThe Lancet, 1991
- Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation, 1991
- Endothelium‐derived nitric oxide: actions and propertiesThe FASEB Journal, 1989
- Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circulation Research, 1987
- Persistent pulmonary hypertension in the neonate: Diagnosis and managementThe Journal of Pediatrics, 1983
- Hemodynamic Effects of Pulmonary Arterial Infusion of Vasodilators in Newborn LambsPediatric Research, 1980
- Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazolineThe Journal of Pediatrics, 1979
- Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1978